摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Sm[OC(CMe3)(2-CH2NC5H3Me-6)2]3 | 165403-96-3

中文名称
——
中文别名
——
英文名称
Sm[OC(CMe3)(2-CH2NC5H3Me-6)2]3
英文别名
——
Sm[OC(CMe3)(2-CH2NC5H3Me-6)2]3化学式
CAS
165403-96-3
化学式
C57H75N6O3Sm
mdl
——
分子量
1042.62
InChiKey
LQFAQHGQVLSQBS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为产物:
    描述:
    3,3-Dimethyl-1-(6-methylpyridin-2-yl)-2-[(6-methylpyridin-2-yl)methyl]butan-2-ol 、 以 正己烷 为溶剂, 以48%的产率得到Sm[OC(CMe3)(2-CH2NC5H3Me-6)2]3
    参考文献:
    名称:
    Synthesis and Structure of Lanthanide Complexes Derived from the O,N-Chelating, Bis(methylpyridine)-Substituted Alcohol HOC(CMe3)(2-CH2NC5H3Me-6)2
    摘要:
    Hydrolysis of the product formed by reacting 2 equiv of 2-(lithiomethylene)-6-methylpyridine with trimethylacetyl chloride gives the alcohol HOC(CMe(3))(2-CH(2)NC(5)H(3)ME-6)(2), 1 (HOR), in 44% yield. Three equivalents of 1 reacts with Yb[N(SiMe(3))(2)](3) to form Yb(OR)(3), 2a. The analogous 2 equiv reaction generates Yb(OR)(2)[N(SiMe(3))(2)], 3. X-ray diffraction studies were successful on 3 and on 2b, the Sm analog of 2a. Two of the alkoxide ligands in Sm(OR)(3), 2b, are bidentate such that each has an uncomplexed nitrogen donor atom oriented away from the metal. These chelates occupy basal positions in the distorted square pyramidal geometry around the metal center in 2b such that the oxygen donors are trans. The axial position is occupied by the third alkoxide which is monodentate through its oxygen donor atom. This leaves a total of four unattached pyridine functionalities available for further coordination. The ligand arrangement in 3 is very similiar to that in 2b except that the monodentate alkoxide in 2b is replaced by a N(SiMe(3))(2) group. A ligand fragmentation product, (R'O)(2)Sm(mu-OR)(2)Na, 4, containing the chelating bidentate pyridine enolate ligand [OC(CMe(3))(=2-CHNC(5)H(3)Me-6)] (OR'), formed by loss of a 2,6-dimethylpyridine group from OR, was also isolated in the course of these studies. Each OR ligand in 4 has its oxygen atom bridging Sm and Na, one pyridine nitrogen coordinated to Na, and one pyridine nitrogen which is not connected to any metal. The samarium center in 4 has a distorted octahedral geometry generated by two chelating R'O groups and the two bridging oxygens from the OR groups. The nitrogen donor atoms of the R'O groups have a cis orientation and are trans to the bridging ligands. The sodium atom has a distorted tetrahedral geometry. 2b crystallizes from toluene in space group P2(1) with a = 11.5464(7) Angstrom, b = 10.7865(5) Angstrom, c = 22.5041(9) Angstrom, beta = 98.930(4)degrees, V = 2768.8(2) Angstrom(3), and Z = 2. Least squares refinement of the model based on 5804 reflections (\F-0\ > 4.0 sigma(\F-0\)) converged to a final R(F) = 2.7%. 3 crystallizes from hexane in space group P (1) over bar with a = 11.109(2) Angstrom, b = 15.135(3) Angstrom, c = 16.197(3) Angstrom, alpha = 96.482(12)degrees, beta = 106.952(10)degrees, gamma = 110.838(10)degrees, V = 2362.0(8) Angstrom(3), and Z = 2. Least squares refinement of the model based on 5596 reflections (\F-0\ > 3.0 sigma(\F-0\)) converged to a final R(F) = 3.8%. 4 crystallizes from hexane in space group P2(1)/n with a = 15.229(4) Angstrom, b = 24.826(4) Angstrom, c = 15.662(3) Angstrom, beta = 97.70(2)degrees, V = 5868(2) Angstrom(3), and Z = 4. Least squares refinement of the model based on 6124 reflections (\F-0\ > 3.0 sigma(\F-0\)) converged to a final R(F) = 5.5%.
    DOI:
    10.1021/ic00118a004
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)